Friday, January 31, 2014

Cara Therapeutics Announces Pricing of Initial Public Offering

SHELTON, Conn. , Jan. 31, 2014 -- Cara Therapeutics, Inc. , a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors, today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price ... (more)



via Shelton Newswire http://ift.tt/1bGJ6tI

No comments:

Post a Comment

Popular Shelton Roundup Posts

More Shelton News

Connecticut News

National News

World News

Business News

Sci/Tech News

Entertainment News

Sports News

Health News